Trade secrets: an alternative for life sciences IP?

Over the past decade, three high-profile US Supreme Court decisions—known by their shorthand names as Alice, Mayo, and Myriad—have generated significant uncertainty over what is and isn’t patentable.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Fenwick hires NY partner to advise on regulatory matters

2 November 2026 New partner joins from Goodwin, where he was a life sciences partner, bringing experience in healthcare transactions, and regulatory and strategic counselling, among other areas.

Regulation & Industry

UK unveils £1bn sector investment push after recent setbacks

30 October 2026 With its goal of becoming a global life sciences leader still some way off, the UK is betting on new investment, AI and regulatory changes to help close the gap, according to the government’s autumn budget.

Careers

Justice Joanna Smith appointed to interim High Court role as Sir Colin Birss replaces Sir Geoffrey Vos

30 October 2026 Mrs Justice Joanna Smith becomes deputy president of the Business and Property Division of the UK High Court, as Sir Colin Birss fills Sir Geoffrey Vos’ shoes as master of the rolls upon his retirement.

More features

Latham lands pharma and tech expert in London

HeartFlow targets AI cardiac imaging rival over patents and trade secrets

‘Companies that don’t leverage AI will struggle to keep up’: Umicore IP chief

Haynes Boone expands in California with new office

Brazilian firm appoints patent strategist to lead department

Scientist and Chinese biotech targeted by Beam in secrets suit

Clifford Chance recruits new head of Asia-Pac

New UK High Court judge named as replacement for Justice Meade

Trade secrets: an alternative for life sciences IP?

More on this story

Editor's picks

Editor's picks

More features